Loading…
Loading…
Did you say you have an incremental 50 to 100 basis point headwind that you are now contemplating in 2Q to 4Q that is getting absorbed in your reiterated gross margin guidance
is that a reasonable place and way to think about it or anything else you would call out
can you describe what's in your base case for any kind of competitive dynamics, possibly even intensifying with Abbott coming out with a dual analyte
You talked about opportunity to take share as consolidation disruption is unfolding. Can you just update us on what you're seeing on that front?
how much of the underlying market strength or pickup in recent quarters or years is attributable to that? And I'm just trying to get a sense for how sustainable a high single-digit growth profile
that would seem to imply that your type 1 segment maybe saw moderating growth leveling off in the single-digit range
how much of the momentum you're seeing there from last quarter or the last few quarters, is that indication versus converting to marketing initiatives direct to patients
Could you just quantify kind of what percentage of the market this potentially just gives you reaccess to
my understanding was that med surg is, you know, over the long-range plan, I would presume in 'twenty-six as well. About positive 100 to 200 basis points
What's your view on fully autonomous robotic your competitor obviously has a solution or wants a solution there
just curious if you can comment at all on U.S. neovascular end market, particularly in the schemics growth
Are you starting to see -- maybe not for the 2025 fiscal years and budget, but are there any behavior changes that are going on?
it looked like you guys got access to the financials and whatnot in early December. It feels like a pretty quick turnaround to diligence
It seems like there's potential to generate real savings to the system here, better patient management post surgery
what is it that ROSA is going to do for the marketplace that Monogram isn't going to use SARPE
If you could just elaborate a little more on what exactly that is, what prompted it